{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:34:15Z","timestamp":1789904055667,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nbd.2018.08.021","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:25:41Z","timestamp":1535754341000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice"],"prefix":"10.1016","volume":"121","author":[{"given":"Ghanashyam D.","family":"Ghadge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Drigotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond P.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.08.021_bb0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boillee","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.08.021_bb0010","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.08.021_bb0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.08.021_bb0020","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.0602046103","article-title":"Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria","volume":"103","author":"Deng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.08.021_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2018.08.021_bb9000","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2018.08.021_bb0030","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.08.021_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2013.04.007","article-title":"Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1","volume":"56","author":"Ghadge","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.08.021_bb0040","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","article-title":"Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS","volume":"113","author":"Gros-Louis","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.08.021_bb0045","doi-asserted-by":"crossref","first-page":"19109","DOI":"10.3390\/ijms140919109","article-title":"Single-chain fragment variable passive immunotherapies for neurodegenerative diseases","volume":"14","author":"Huang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2018.08.021_bb0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2018.08.021_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.sbi.2014.05.011","article-title":"Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs","volume":"27","author":"Jost","year":"2014","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.nbd.2018.08.021_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.08.021_bb0065","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1523\/JNEUROSCI.5053-11.2012","article-title":"Targeting of monomer\/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis","volume":"32","author":"Liu","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.08.021_bb0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2018.08.021_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/mt.2013.239","article-title":"Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis","volume":"22","author":"Patel","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2018.08.021_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrneurol.2012.258","article-title":"Immunotherapy in prion disease","volume":"9","author":"Roettger","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2018.08.021_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.08.021_bb0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/mt.2014.129","article-title":"ESCRT-mediated uptake and degradation of brain-targeted alpha-synuclein single chain antibody attenuates neuronal degeneration in Vivo","volume":"22","author":"Spencer","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2018.08.021_bb0095","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/NEN.0b013e3181f4a90a","article-title":"Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice","volume":"69","author":"Takeuchi","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.08.021_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.08.021_bb0105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1073\/pnas.0606201104","article-title":"Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis","volume":"104","author":"Urushitani","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.08.021_bb0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nbd.2007.10.004","article-title":"Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology","volume":"29","author":"Wang","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.08.021_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2009.05.002","article-title":"The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis","volume":"35","author":"Wang","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.08.021_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/hmg\/ddq463","article-title":"Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.08.021_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nbd.2012.05.014","article-title":"Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice","volume":"48","author":"Wang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.08.021_bb0130","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/hmg\/ddt658","article-title":"An enhanced integrated stress response ameliorates mutant SOD1-induced ALS","volume":"23","author":"Wang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.08.021_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.20228","article-title":"Gait analysis detects early changes in transgenic SOD1(G93A) mice","volume":"32","author":"Wooley","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2018.08.021_bb0140","doi-asserted-by":"crossref","first-page":"16691","DOI":"10.1074\/jbc.M609743200","article-title":"Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118305205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118305205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T20:43:30Z","timestamp":1720557810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118305205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"alternative-id":["S0969996118305205"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.08.021","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}